Literature DB >> 28599447

Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.

Ladan Dawoody Nejad1,2, Alireza Biglari3, Tiziana Annese4, Domenico Ribatti4,5.   

Abstract

Constitutive activation of nuclear factor-κB (NF-κB) stimulates cell proliferation and metastasis, and inhibits apoptosis in breast cancer. Transforming growth factor-β (TGF-β) signaling pathway is deregulated in breast cancer progression and metastasis. The aim of the present study was to investigate the inhibitory effects of the two small leucine rich proteoglycans fibromodulin (Fmod) and decorin (Dcn), overexpressed using adenovirus gene transfer, on NF-κB-activity and TGF-β1-expression in the highly metastatic 4T1 breast cancer cell line. The results demonstrate that Fmod and Dcn overexpression is associated with NF-κB and TGF-β1 downregulation, and that Fmod promotes this effect more effectively compared with Dcn.

Entities:  

Keywords:  adenoviral vector; breast cancer; decorin; fibromodulin; nuclear factor-κB; transforming growth factor-β1

Year:  2017        PMID: 28599447      PMCID: PMC5452964          DOI: 10.3892/ol.2017.5960

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  49 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer.

Authors:  C E Appleby; P A Kingston; A David; C A Gerdes; P Umaña; M G Castro; P R Lowenstein; A M Heagerty
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

Review 4.  Rel/NF-kappa B and I kappa B proteins: an overview.

Authors:  M J May; S Ghosh
Journal:  Semin Cancer Biol       Date:  1997-04       Impact factor: 15.707

5.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

6.  Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.

Authors:  Jonine D Figueroa; Kathleen C Flanders; Montserrat Garcia-Closas; William F Anderson; Xiaohong R Yang; Rayna K Matsuno; Máire A Duggan; Ruth M Pfeiffer; Akira Ooshima; Robert Cornelison; Gretchen L Gierach; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Lalage M Wakefield; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2009-11-24       Impact factor: 4.872

7.  TGF-β Signaling in Cancer.

Authors:  Viqar Syed
Journal:  J Cell Biochem       Date:  2016-02-11       Impact factor: 4.429

Review 8.  Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.

Authors:  Silvia Goldoni; Renato V Iozzo
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

9.  Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Gregory S Schultz; John W Cowden; Ashish Tandon
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

Review 10.  NF-κB, stem cells and breast cancer: the links get stronger.

Authors:  Kateryna Shostak; Alain Chariot
Journal:  Breast Cancer Res       Date:  2011-07-26       Impact factor: 6.466

View more
  6 in total

1.  Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin.

Authors:  Lia Farahi; Fatemeh Ghaemimanesh; Saeideh Milani; Seyed Mohsen Razavi; Ali Ahmad Bayat; Hodjattallah Rabbani; Mohammad Mehdi Akhondi
Journal:  Iran J Biotechnol       Date:  2019-01-11       Impact factor: 1.671

Review 2.  The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy.

Authors:  Mohammad Hossein Pourhanifeh; Rezvan Mohammadi; Somaye Noruzi; Seyede Atefe Hosseini; Sahar Fanoudi; Yousef Mohamadi; Milad Hashemzehi; Zatollah Asemi; Hamid Reza Mirzaei; Reza Salarinia; Hamed Mirzaei
Journal:  Cancer Cell Int       Date:  2019-06-10       Impact factor: 5.722

Review 3.  Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases.

Authors:  Jinyang Zeng-Brouwers; Sony Pandey; Jonel Trebicka; Malgorzata Wygrecka; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 4.  Decorin-mediated oncosuppression - a potential future adjuvant therapy for human epithelial cancers.

Authors:  Annele Orvokki Sainio; Hannu Tapio Järveläinen
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

5.  Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Takumi Kawaguchi; Sachiyo Yoshio; Yuzuru Sakamoto; Ryuki Hashida; Shunji Koya; Keisuke Hirota; Dan Nakano; Sakura Yamamura; Takashi Niizeki; Hiroo Matsuse; Takuji Torimura
Journal:  J Clin Med       Date:  2020-03-28       Impact factor: 4.241

Review 6.  Proteoglycans in Biomedicine: Resurgence of an Underexploited Class of ECM Molecules.

Authors:  Tanaya Walimbe; Alyssa Panitch
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.